Literature DB >> 21502316

Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach.

Jose Renato Pinto1, Shi Wei Yang, Marc-Phillip Hitz, Michelle S Parvatiyar, Michelle A Jones, Jingsheng Liang, Victor Kokta, Mario Talajic, Nicolas Tremblay, Michelle Jaeggi, Gregor Andelfinger, James D Potter.   

Abstract

A novel double deletion in cardiac troponin T (cTnT) of two highly conserved amino acids (Asn-100 and Glu-101) was found in a restrictive cardiomyopathic (RCM) pediatric patient. Clinical evaluation revealed the presence of left atrial enlargement and marked left ventricle diastolic dysfunction. The explanted heart examined by electron microscopy revealed myofibrillar disarray and mild fibrosis. Pedigree analysis established that this mutation arose de novo. The patient tested negative for six other sarcomeric genes. The single and double recombinant cTnT mutants were generated, and their functional consequences were analyzed in porcine skinned cardiac muscle. In the adult Tn environment (cTnT3 + cardiac troponin I), the single cTnT3-ΔN100 and cTnT3-ΔE101 mutations had opposing effects on the Ca(2+) sensitivity of force development compared with WT, whereas the double deletion cTnT3-ΔN100/ΔE101 increased the Ca(2+) sensitivity + 0.19 pCa units. In addition, cTnT3-ΔN100/ΔE101 decreased the cooperativity of force development, suggesting alterations in intrafilament protein-protein interactions. In the fetal Tn environment, (cTnT1 + slow skeletal troponin I), the single (cTnT1-ΔN110) and double (cTnT1-ΔN110/ΔE111) deletions did not change the Ca(2+) sensitivity compared with control. To recreate the patient's heterozygous genotype, we performed a reconstituted ATPase activity assay. Thin filaments containing 50:50 cTnT3-ΔN100/ΔE101:cTnT3-WT also increased the myofilament Ca(2+) sensitivity compared with WT. Co-sedimentation of thin filament proteins indicated that no significant changes occurred in the binding of Tn containing the RCM cTnT mutation to actin-Tm. This report reveals the protective role of Tn fetal isoforms as they rescue the increased Ca(2+) sensitivity produced by a cTnT-RCM mutation and may account for the lack of lethality during gestation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502316      PMCID: PMC3121488          DOI: 10.1074/jbc.M111.234336

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Deletion in TNNI3 gene is associated with restrictive cardiomyopathy.

Authors:  Anna Kostareva; Alexandra Gudkova; Gunnar Sjöberg; Stellan Mörner; Eugene Semernin; Alexander Krutikov; Eugene Shlyakhto; Thomas Sejersen
Journal:  Int J Cardiol       Date:  2007-11-14       Impact factor: 4.164

2.  A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy.

Authors:  Simon Karam; Marie-Josée Raboisson; Corinne Ducreux; Lara Chalabreysse; Gilles Millat; André Bozio; Patrice Bouvagnet
Journal:  Congenit Heart Dis       Date:  2008 Mar-Apr       Impact factor: 2.007

3.  Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo.

Authors:  Kiyomasa Nishii; Sachio Morimoto; Reiko Minakami; Yumi Miyano; Kanako Hashizume; Mika Ohta; Dong-Yun Zhan; Qun-Wei Lu; Yosaburo Shibata
Journal:  Dev Biol       Date:  2008-07-16       Impact factor: 3.582

4.  Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants.

Authors:  Jennifer Davis; Haitao Wen; Terri Edwards; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2008-02-26       Impact factor: 5.000

5.  Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

Authors:  Franz Baudenbacher; Tilmann Schober; Jose Renato Pinto; Veniamin Y Sidorov; Fredrick Hilliard; R John Solaro; James D Potter; Björn C Knollmann
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

6.  A functional and structural study of troponin C mutations related to hypertrophic cardiomyopathy.

Authors:  Jose Renato Pinto; Michelle S Parvatiyar; Michelle A Jones; Jingsheng Liang; Michael J Ackerman; James D Potter
Journal:  J Biol Chem       Date:  2009-05-12       Impact factor: 5.157

7.  Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease.

Authors:  Cristina Chimenti; Nazha Hamdani; Nicky M Boontje; Francesco DeCobelli; Antonio Esposito; Jean G F Bronzwaer; Ger J M Stienen; Matteo A Russo; Walter J Paulus; Andrea Frustaci; Jolanda van der Velden
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

8.  Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.

Authors:  J P Kaski; P Syrris; M Burch; M-T Tomé-Esteban; M Fenton; M Christiansen; P S Andersen; N Sebire; M Ashworth; J E Deanfield; W J McKenna; P M Elliott
Journal:  Heart       Date:  2008-05-08       Impact factor: 5.994

9.  Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology.

Authors:  S C Menon; V V Michels; P A Pellikka; J D Ballew; M L Karst; K J Herron; S M Nelson; R J Rodeheffer; T M Olson
Journal:  Clin Genet       Date:  2008-07-21       Impact factor: 4.438

10.  The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.

Authors:  Ferhaan Ahmad; Sanjay K Banerjee; Michele L Lage; Xueyin N Huang; Stephen H Smith; Samir Saba; Jennifer Rager; David A Conner; Andrzej M Janczewski; Kimimasa Tobita; Joseph P Tinney; Ivan P Moskowitz; Antonio R Perez-Atayde; Bradley B Keller; Michael A Mathier; Sanjeev G Shroff; Christine E Seidman; J G Seidman
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more
  10 in total

Review 1.  Genetics and disease of ventricular muscle.

Authors:  Diane Fatkin; Christine E Seidman; Jonathan G Seidman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

2.  Engineered troponin C constructs correct disease-related cardiac myofilament calcium sensitivity.

Authors:  Bin Liu; Ryan S Lee; Brandon J Biesiadecki; Svetlana B Tikunova; Jonathan P Davis
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

3.  The effects of slow skeletal troponin I expression in the murine myocardium are influenced by development-related shifts in myosin heavy chain isoform.

Authors:  Steven J Ford; Murali Chandra
Journal:  J Physiol       Date:  2012-09-10       Impact factor: 5.182

4.  Basic residues within the cardiac troponin T C terminus are required for full inhibition of muscle contraction and limit activation by calcium.

Authors:  Dylan Johnson; Li Zhu; Maicon Landim-Vieira; Jose Renato Pinto; Joseph M Chalovich
Journal:  J Biol Chem       Date:  2019-11-11       Impact factor: 5.157

5.  Eliminating the First Inactive State and Stabilizing the Active State of the Cardiac Regulatory System Alters Behavior in Solution and in Ordered Systems.

Authors:  Dylan Johnson; Maicon Landim-Vieira; Christopher Solı S; Li Zhu; John M Robinson; Jose R Pinto; Joseph M Chalovich
Journal:  Biochemistry       Date:  2020-09-09       Impact factor: 3.321

6.  Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation.

Authors:  Tiago Veltri; Maicon Landim-Vieira; Michelle S Parvatiyar; David Gonzalez-Martinez; Karissa M Dieseldorff Jones; Clara A Michell; David Dweck; Andrew P Landstrom; P Bryant Chase; Jose R Pinto
Journal:  Front Physiol       Date:  2017-04-20       Impact factor: 4.566

7.  Impact of DYRK1A Expression on TNNT2 Splicing and Daunorubicin Toxicity in Human iPSC-Derived Cardiomyocytes.

Authors:  Romina Beatriz Cejas; Miriam Tamaño-Blanco; John Edgar Fontecha; Javier Guillermo Blanco
Journal:  Cardiovasc Toxicol       Date:  2022-05-21       Impact factor: 2.755

8.  Inherited cardiomyopathies caused by troponin mutations.

Authors:  Qun-Wei Lu; Xiao-Yan Wu; Sachio Morimoto
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

9.  Pediatric restrictive cardiomyopathy due to a heterozygous mutation of the TNNI3 gene.

Authors:  Yan Chen; Shiwei Yang; Jun Li; Gannan Wang; Yuming Qin; Daowu Wang; Kejiang Cao
Journal:  J Biomed Res       Date:  2013-04-20

Review 10.  Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review.

Authors:  Siobhan Simpson; Paul Rutland; Catrin Sian Rutland
Journal:  Vet Sci       Date:  2017-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.